HelpAcademyLoginJoin us as a Member

Zai Lab Ltd

Sign in to save Zai Lab Ltd to a watchlist Sign in to set an alert for Zai Lab Ltd
Tickers
ZLAB
Headquarters
Not recorded
SEC CIK
0001704292
Website
Not recorded

Closing prices

Latest close, 22.36

Closing prices for ZLAB249 stored closes for ZLAB from 3 Nov 2025 to 29 Oct 2026. Lowest 16.30 on 2 Feb 2026, highest 27.00 on 3 Sep 2026, latest 22.36 on 29 Oct 2026.Close15.0020.0025.0030.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Source: Massive Closing prices as of End-of-day prices, not live

Massive Basic, non-business use; display licence needed before launch (D-1). Marketstack is kept as the backup source.

Not investment advice. End-of-day closing prices, not live quotes.

Drugs

Drugs from Zai Lab Ltd
DrugIndicationsPhaseNext catalystCT-VCATrials
ZL-1310Not yet reviewed: Listed from FDA or ClinicalTrials.gov records; an editor has not checked it yet Sign in to save ZL-1310 to a watchlist Small-cell Lung CancerPhase 3None scheduledNo published CT-VCA score1

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Latest value of each metric as reported to the SEC
MetricReported valuePeriodFiling
Revenue106,311,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Revenue on sec.gov (opens in a new tab)Filed
Net income (loss)−50,825,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Net income (loss) on sec.gov (opens in a new tab)Filed
Research and development expense61,766,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Research and development expense on sec.gov (opens in a new tab)Filed
Operating expensesNot reported in XBRL filings since 2015
Cash and cash equivalents607,522,000 USD At 30 Jun 2026 FY2026 Q210-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed
Short-term investments and marketable securities10,000,000 USD At 30 Jun 2026 FY2026 Q210-Q for Short-term investments and marketable securities on sec.gov (opens in a new tab)Filed
Total liabilities467,756,000 USD At 30 Jun 2026 FY2026 Q210-Q for Total liabilities on sec.gov (opens in a new tab)Filed
Stockholders' equity607,037,000 USD At 30 Jun 2026 FY2026 Q210-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed
Common shares outstanding (cover page)88,592,343 shares At 26 Feb 2021 FY202010-K for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed

History

Revenue, newest period first
PeriodReported valueFiling
1 Apr 2026 to 30 Jun 2026 FY2026 Q2106,311,000 USD10-Q filed 6 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2026 to 31 Mar 2026 FY2026 Q199,611,000 USD10-Q filed 7 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Dec 2025 FY2025460,156,000 USD10-K filed 26 Feb 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2025 to 30 Sep 2025 FY2025 Q3116,095,000 USD10-Q filed 6 Nov 2025 on sec.gov (opens in a new tab)Filed
1 Apr 2025 to 30 Jun 2025 FY2026 Q2109,977,000 USD10-Q filed 6 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Mar 2025 FY2026 Q1106,487,000 USD10-Q filed 7 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2024 to 31 Dec 2024 FY2025398,988,000 USD10-K filed 26 Feb 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2024 to 30 Sep 2024 FY2025 Q3102,265,000 USD10-Q filed 6 Nov 2025 on sec.gov (opens in a new tab)Filed

The newest 12 periods of each metric are listed; older ones are on sec.gov.

Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.

Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-25 · read

SEC filings

SEC filings from Zai Lab Ltd, newest first
FormFiledWhat it coversDocument
8-KEvent 22 Oct 2026 Current report (8-K)
  • Entry into a material definitive agreement (Item 1.01)
  • Unregistered sales of equity securities (Item 3.02)
  • Regulation FD disclosure (Item 7.01)
  • Other events (Item 8.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 23 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001628280-26-066969 (opens in a new tab)
4Event 1 Oct 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 5 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-004359 (opens in a new tab)
4Event 19 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 21 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003867 (opens in a new tab)
4Event 14 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 18 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003804 (opens in a new tab)
4Event 12 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 13 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003620 (opens in a new tab)
4Event 11 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 13 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003619 (opens in a new tab)
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 6 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001628280-26-053793 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 6 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001628280-26-053791 (opens in a new tab)
4Event 1 Jul 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 6 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003169 (opens in a new tab)
4Event 1 Jul 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 6 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0000905148-26-003167 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for Zai Lab Ltd on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
3 transactions, 9,385 shares, $235,145
Other all other codes
2 transactions: grants, exercises, tax withholding, gifts and similar

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.